TORONTO--(BUSINESS WIRE)--BioPharma Services Inc. (BPSI) announces the creation of the Lorelei Lutter Fine Arts Scholarship (LLFAS) in memory of Lorelei Lutter, VP Business Development. The scholarship is meant to be a reflection of Lorelei’s love of fine arts.
The first scholarship will be awarded in August 2014 to a dependant child of a BioPharma employee who shows extraordinary talent in an eligible fine arts genre and who demonstrates good academic and personal standings. Direct dependants will be considered first. “We are very pleased to honor Lorelei in her area of passion and love,” commented Renzo DiCarlo, CEO of BioPharma Services Inc.
The recipient of the annual award will be communicated in the month of August during the annual BPSI BBQ.
About BioPharma Services Inc. BioPharma Services Inc. is a physician-owned, physician-run, FDA-inspected, UK MHRA-inspected, and Health Canada-inspected International Contract Research Organisation (CRO) which specializes in the conduct of Phase I/IIa clinical trials and bioanalysis for innovative pharmaceutical, biotech and medical device companies from US, Canada, Australia and Europe. The company currently has a modern 174-bed clinical facility and a co-located bioanalytical laboratory in Toronto, Canada. The company is privately held and is headquartered in Toronto, Canada.